Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Calfactant for Direct Acute Respiratory Distress Syndrome (CARDS)
This study has been terminated.
( Expected mortality rates in placebo and treatment groups lower than predicted )
Study NCT00682500 Information provided by Pneuma Pharmaceuticals Incorporated
First Received on May 20, 2008. Last Updated on July 23, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Acute Lung Injury
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
More general conditions related to this trial
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Calfactant
Room Air (placebo)
More general drug interventions related to this trial
Pharmacologic Actions
Pulmonary Surfactants
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pneuma Pharmaceuticals Incorporated
Back to top of Main Content